PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers

Molecular Psychiatry

Volumn 7, Issue SUPPL. 1, 2002, Pages

  Manji, H K ^a   Chen, G ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antidepressant; Bipolar; Cell survival; Lithium; Manic; MAP kinase; Neuroplasticity

Indexed keywords

LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE C; TAMOXIFEN; VALPROIC ACID;

ARTICLE; CELL SURVIVAL; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANTICONVULSANTS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MOOD DISORDERS; NEURONAL PLASTICITY; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0036220487     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/mp/4001018     Document Type: Article

References (64)

1. Role of receptor coupling to phosphoinositide metabolism in the therapeutic action of lithium
2. The cellular neurobiology of depression
3. Neuroimaging studies of mood disorders
4. The neurochemistry of mood disorders clinical studies
5. Signal transduction abnormalities in bipolar disorder
6. Toward an integrated biological model of bipolar disorder
7. Emergent properties of networks of biological signaling pathways
8. Lithium and brain signal transduction systems
9. Temporal dissociation between lithium-induced CNS myo-inositol changes and clinical response in manic-depressive illness
10. Anti-bipolar therapy: Mechanism of action of lithium
11. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of bipolar disorder
12. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder
13. Neuroplasticity and cellular resilience in mood disorders. Millennium article
14. Protein kinase C
15. Protein kinase C: Structure, function and regulation
16. Protein kinase C and lipid signaling for sustained cellular responses
17. Lithium decreases membrane-associated protein kinase C in hippocampus: Selectivity for the ∞ isozyme
18. Mood stabilizers regulate cytoprotective and mRNA binding proteins in the brain: Long term effects on cell survival and transcript stability
19. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus
20. Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro
21. Protein kinase C in the nervous system
22. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high dose tamoxifen
23. A preliminary investigation of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania
24. Initiation and adaptation: A paradigm for understanding psychotropic drug action
25. A new intellectual framework for psychiatry
26. Molecular mechanisms underlying mood-stabilization in manic-depressive illness: The phenotype challenge
27. Do animal models have a place in the genetic analysis of quantitative human behavioral traits?
28. Signaling: Cellular insights into the pathophysiology of bipolar disorder
29. The mood stabilizing agents lithium and valproate robustly increase the expression of the neuroprotective protein bcl-2 in the CNS
30. Lithium at 50: Have the neuroprotective effects of this unique medication been overlooked?
31. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder
32. Enhancement of hippocampal neurogenesis by lithium
33. Long term lithium treatment suppresses p53 and Bax expression but increases bcl-2 expression
34. Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells
35. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats
36. BDNF promotes the survival and sprouting of serotonergic axons in the rat brain
37. Programmed cell death in animal development
38. Neuronal cell death
39. Neurotrophins and neuronal plasticity
40. Intracellular signaling pathways activated by neurotrophic factors
41. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism
42. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons
43. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
44. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades
45. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation
46. MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term life facilitation in Aplysia
47. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus
48. Antidepressant treatments in the 21st century
49. 2-terminal kinases (JNKs) in vitro and in the CNS in vivo
50. The mood-stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth
51. CREB couples neurotrophin signals to survival messages
52. Impairments of neuroplasticity and cellular resilience in severe mood disorders: Implications for the development of novel therapeutics
53. Stress and hippocampal plasticity
54. Neuronal plasticity and survival in mood disorders
55. Subgenual prefrontal cortex abnormalities in mood disorders
56. N-acetylaspartate in neuropsychiatric disorders
57. Lithium increases N-acetylaspartate in the human brain: In vivo evidence in support of blc-2's neurotrophic effects?
58. Lithium-induced increase in human brain gray matter
59. Depression duration but not age predicts hippocampal volume loss in medical healthy women with recurrent major depression
60. Structural brain abnormalities in first-episode mania
61. Subgenual cingulate cortex volume in first-episode psychosis
62. Signal transduction abnormalities in bipolar affective disorder
63. Designing small-molecule switches for protein-protein interactions